profit from every $100 of sales.
$0$100
Avadel Pharmaceuticals
We have no price for Avadel Pharmaceuticals since 13 February 2026. It may have been taken over, merged or renamed, so the figures below are from then.
$21.64+0.00% today
+52.3% since Oct 8, 25
1-year low $14.001-year high $23.56
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Avadel Pharmaceuticals vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Avadel Pharmaceuticals | No profit yet | ||
 Merck KGaA | 25.3× · Fair price | ||
 Takeda Pharmaceutical | 98.8× · Very expensive | ||
 Galderma Group | 89.1× · Very expensive | ||
 Teva Pharmaceutical Industries | 35.8× · Expensive |
AI analysis
An AI analyst reads Avadel Pharmaceuticals's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- 28.3×
- –
- 21.4×
- 12.6×
- –
- 205.5×
- -2.2%
- -2.3%
- 0.0%
Profitability
- 94.5%
- 1.8%
- -0.1%
- 4.1%
- 0.3%
- -79.9%
- -0.3%
- -0.1%
- 3.3%
- 16.1%
Growth
- +65.9%
- –
- +63.5%
- –
- +15.8%
Financial health
- -4.2×
- 0.38
- 18.7%
- 0.5×
- 2.76
- 2.37
- 1.25
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 34%of 958
Bottom 30%of 889
Top 9%of 890
Bottom 27%of 987
What analysts expect
- Average price target
- $22.50
- Range
- $22.50 – $22.50
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Mar 2, 2026 | -0.05 | 0.08 | −162.5% |
| Aug 7, 2025 | 0.10 | 0.02 | +400.0% |
| May 7, 2025 | -0.05 | -0.07 | +28.6% |
| Mar 3, 2025 | -0.05 | -0.05 | +0.0% |
| Nov 12, 2024 | -0.03 | -0.06 | +50.0% |
| Aug 8, 2024 | -0.14 | -0.17 | +17.6% |
| May 8, 2024 | -0.30 | -0.25 | −20.0% |
| Mar 4, 2024 | -0.32 | -0.28 | −14.3% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
38No pass
Philip Fisher
52No pass
Peter Lynch
75Pass
Joel Greenblatt
2No pass
Charlie Munger
47No pass
Terry Smith
54No pass
Questions about Avadel Pharmaceuticals
Is Avadel Pharmaceuticals a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Avadel Pharmaceuticals AI analysis
What does Avadel Pharmaceuticals do?
Avadel Pharmaceuticals plc is a biopharmaceutical firm primarily conducting its operations within the United States. The company's flagship investigational drug, FT218, a specialized compound of sodium oxybate, is currently in Phase 3 clinical trials. It is in Drug Manufacturers - Specialty & Generic.
Does Avadel Pharmaceuticals pay a dividend?
No. Avadel Pharmaceuticals does not pay a dividend at the moment.
Is Avadel Pharmaceuticals stock halal?
Yes. Avadel Pharmaceuticals passes our halal screen: its business is permitted and its debt is 0% of its market value, under the 30% limit. How we check
Who are Avadel Pharmaceuticals's competitors?
The largest listed companies in the same industry are Merck KGaA, Takeda Pharmaceutical, Galderma Group and Teva Pharmaceutical Industries. The peers table on this page compares their profit, growth and price with Avadel Pharmaceuticals's.
Prices: daily closes to Feb 13, 2026. Fundamentals: company reports via invest-like data.